Today, AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The Mosai ...

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

Having psoriasis raises your risk of psoriatic arthritis — and rheumatoid arthritis, too. Make sure you can tell these two forms of arthritis apart.

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been ...

Increasing wildfire incidence, along with greater overall air pollution, may be contributing to risks for rheumatoid arthritis and RA-associated interstitial lung disease, according to findings ...

Patients with psoriatic arthritis (PsA) experienced longer diagnostic delays than matched patients with rheumatoid arthritis (RA). Patients with polyarticular PsA received less intensive disease ...

A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, according to researchers at the University of Wisconsin–Madison. The drug ...

Increasing wildfire incidence, along with greater overall air pollution, may be contributing to risks for rheumatoid ...

Lags in Psoriatic Arthritis vs Rheumatoid Arthritis Care Patients with psoriatic arthritis experience longer delays in diagnosis, receive less intensive therapy, and show less improvement in ...

Cullinan Therapeutics (CGEM) announced that the European Medicines Agency, EMA, approved the Company’s Clinical Trial Application, CTA, for ...